tradingkey.logo

Ekso Bionics Holdings Inc

EKSO
10.410USD
+1.050+11.22%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
27.31MValor de mercado
PerdaP/L TTM

Ekso Bionics Holdings Inc

10.410
+1.050+11.22%

Mais detalhes de Ekso Bionics Holdings Inc Empresa

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Informações de Ekso Bionics Holdings Inc

Código da empresaEKSO
Nome da EmpresaEkso Bionics Holdings Inc
Data de listagemApr 10, 2013
CEODavis (Scott G)
Número de funcionários61
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 10
Endereço101 Glacier Point
CidadeSAN RAFAEL
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94901
Telefone15109841761
Sitehttps://eksobionics.com/
Código da empresaEKSO
Data de listagemApr 10, 2013
CEODavis (Scott G)

Executivos da empresa Ekso Bionics Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+15747.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
18.59K
-1320.00%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-1238.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
+15747.00%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+15747.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
18.59K
-1320.00%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-1238.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
+15747.00%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
3.16M
74.78%
Other EMEA
428.00K
10.13%
France
363.00K
8.59%
APAC
253.00K
5.99%
Other Americas
22.00K
0.52%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 1 de fev
Atualizado em: dom, 1 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Asher (Daniel)
19.98%
Davis (Scott Gerald)
2.33%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
Li (Kecheng)
0.91%
Outro
74.61%
Investidores
Investidores
Proporção
Asher (Daniel)
19.98%
Davis (Scott Gerald)
2.33%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
Li (Kecheng)
0.91%
Outro
74.61%
Tipos de investidores
Investidores
Proporção
Individual Investor
26.52%
Investment Advisor
1.86%
Hedge Fund
1.57%
Investment Advisor/Hedge Fund
0.97%
Research Firm
0.33%
Family Office
0.03%
Outro
68.71%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
64
261.39K
8.72%
--
2025Q3
67
261.39K
11.41%
+205.54K
2025Q2
64
55.85K
14.40%
-195.55K
2025Q1
62
251.40K
15.39%
-37.98K
2024Q4
61
283.25K
26.99%
-87.09K
2024Q3
58
370.34K
18.68%
+159.85K
2024Q2
61
145.58K
14.28%
+25.92K
2024Q1
67
120.72K
11.67%
-18.52K
2023Q4
71
95.15K
14.09%
+2.45K
2023Q3
71
92.88K
16.51%
-13.62K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Davis (Scott Gerald)
78.95K
2.33%
+56.69K
+254.58%
Nov 10, 2025
Citadel Advisors LLC
38.55K
1.14%
+38.55K
--
Sep 30, 2025
The Vanguard Group, Inc.
35.45K
1.04%
+23.49K
+196.31%
Sep 30, 2025
Li (Kecheng)
30.73K
0.91%
+15.75K
+105.11%
May 16, 2025
Lathan (Corinna)
25.61K
0.75%
+15.75K
+159.61%
May 16, 2025
Cloyd (Mary Ann)
25.23K
0.74%
+15.75K
+166.00%
May 16, 2025
DRW Securities, LLC
20.19K
0.6%
+20.19K
--
Sep 30, 2025
Jones (Jason C)
19.91K
0.59%
-270.00
-1.34%
Dec 09, 2025
Cresset Asset Management, LLC
17.96K
0.53%
--
--
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Data
Data ex-dividendo
Tipo
Proporção
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
KeyAI